Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide).

The objective was to evaluate the stability of nanoparticles prepared with poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers and stored at different temperatures and in different media. The stability parameters studied were molecular weight and crystallinity of the polymer, nanoparticle size and pH. The results show that the stability of polymeric nanoparticles depends on (i) the type of polymers with the following increasing order of polymer stability: PLA25GA50 < PLA37.5GA25 < PLA50 = PCL, (ii) the storage temperature: PCL and PLA50 nanoparticles can be kept at 4 degrees C and RT during one year, while PLA37.5GA25 and PLA25GA50 nanoparticles have to be stored at 4 degrees C, and (iii) the storage conditions: buffering or freeze-drying nanoparticles improves stability.

[1]  Michel Vert,et al.  Morphological changes resulting from the hydrolytic degradation of stereocopolymers derived from L- and DL-lactides , 1994 .

[2]  H. Yamanaka,et al.  Biodegradable implant composites for local therapy , 1987 .

[3]  R. Linhardt,et al.  Degradation and release properties of pellets fabricated from three commercial poly(D,L-lactide-co-glycolide) biodegradable polymers. , 1993, Journal of pharmaceutical sciences.

[4]  T. Kondo,et al.  Mechanism of hydrolytic degradation of poly(L-lactide) microcapsules: effects of pH, ionic strength and buffer concentration. , 1986, Journal of microencapsulation.

[5]  Michel Vert,et al.  MORE ABOUT THE DEGRADATION OF LA/GA – DERIVED MATRICES IN AQUEOUS MEDIA , 1991 .

[6]  R. Langer,et al.  Biodegradable polymers as drug delivery systems , 1990 .

[7]  T. Chang,et al.  In-vivo degradation of poly(lactic acid) of different molecular weights. , 1985, Biomaterials, medical devices, and artificial organs.

[8]  G. Gregoriadis.  Drug carriers in biology and medicine , 1979 .

[9]  S. Li,et al.  Attempts to map the structure and degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. , 1994, Journal of biomaterials science. Polymer edition.

[10]  Suming Li,et al.  Biodegradation of PLA/GA polymers: increasing complexity. , 1994, Biomaterials.

[11]  D. Crommelin,et al.  Controlled release of bioactive agents from lactide/glycolide polymers , 1990 .

[12]  A. M. Reed,et al.  Biodegradable polymers for use in surgery — poly(glycolic)/poly(Iactic acid) homo and copolymers: 2. In vitro degradation , 1981 .

[13]  T. Kondo,et al.  Preparation and in vitro degradation properties of polylactide microcapsules. , 1985, Chemical & pharmaceutical bulletin.

[14]  J. Benoit,et al.  In vitro and in vivo degradation of poly(D,L lactide/glycolide) type microspheres made by solvent evaporation method. , 1989, Biomaterials.

[15]  Michel Vert,et al.  Structure-property relationships in the case of the degradation of massive poly(α-hydroxy acids) in aqueous media , 1990 .

[16]  J. A. Hubbell,et al.  Rapidly degraded terpolymers of dl-lactide, glycolide, and epsilon-caprolactone with increased hydrophilicity by copolymerization with polyethers. , 1990, Journal of biomedical materials research.

[17]  Tae Gwan Park,et al.  Degradation of poly(d,l-lactic acid) microspheres: effect of molecular weight , 1994 .

[18]  D. Pichora,et al.  An Investigation of Poly(lactic acid) Degradation , 1994 .

[19]  C. G. Pitt,et al.  The biodegradability of polyester blends. , 1990, Biomaterials.

[20]  P. Nair,et al.  Multiple gamma radiation sterilization of polyester fibres. , 1988, Biomaterials.

[21]  Brian J. Tighe,et al.  Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecular release systems , 1986 .